TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab
- Status
- COMPLETED
- Phase
- N/A
Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study
- Status
- COMPLETED
- Phase
- PHASE2
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
- Status
- RECRUITING
- Phase
- N/A
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Biomarkers for Risk Stratification in Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative
- Status
- UNKNOWN
- Phase
- PHASE2
NGS Combined With RNAseq on Tumor Immune Escape in NSCLC
- Status
- UNKNOWN
- Phase
- N/A
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2